Hunter Syndrome

• FDA approval · 2018-11-16
  FDA Approved: ELAPRASE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

  The FDA approved a supplemental application for Elaprase (idursulfase) by Takeda Pharmaceuticals America, Inc., related to changes or additi…

• FDA approval ·
  FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome

  FDA approved Avlayah (tividenofusp alfa-eknm) to treat neurologic manifestations in individuals with Hunter syndrome (MPS II).